Opioid conflict-of-interest controversy reveals extent of big pharma's ties to doctors
Controversy over drug industry conflicts on opioid-prescribing guidelines has Ottawa asking questions. But industry influence on doctors is widespread and widely accepted — if rarely discussed.
Aucun commentaire:
Enregistrer un commentaire